10.1089/ars.2009.3074
This allows them to pass intact to the small intestine, where absorption occurs
However, Vyvanse is not approved to treat obesity or to promote weight loss
Special Considerations for Dehydration Risk Severe vomiting or diarrhoea can cause dehydration and potentially worsen kidney function
Background There were two GLP-1 products that were initially approved and marketed for treating type-2 diabetes but, because they also had successful weight loss results, the manufacturers each got FDA approval to sell the products under two separate indications, one indicated for type 2 diabetes and one for weight loss, each with its own brand name and National Drug Code (NDC) identification number
For Luker-Stewart, a bar owner and real estate agent, Ozempic and later tirzepatide, the active ingredient in drugs like Mounjaro and Zepbound hasnt just affected his nightlife